InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 14.66
+0.39 (2.73%)
Aug 20, 2026, 4:09 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 30.91 billion as of August 20, 2026. Its market cap has decreased by -17.64% in one year.
Market Cap
30.91B
Enterprise Value
24.93B
Revenue
2.87B
Ranking
n/a
PE Ratio
29.71
Stock Price
14.66
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 30.91B, an increase of 151.75%. That is a compound annual growth rate of 15.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 30.91B | 30.49% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 71.98B |
| Biocytogen Pharmaceuticals (Beijing) | 62.08B |
| Genscript Biotech | 57.07B |
| 3SBio | 43.54B |
| Shanghai Junshi Biosciences | 40.62B |
| Shanghai Henlius Biotech | 37.39B |
| Zai Lab | 22.82B |
| Keymed Biosciences | 22.79B |